Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxepin for insomnia (verification clinical trial)
CTR20230027Phase 3Completed
- Sponsor
- Shenyang Funing Pharmaceutical
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxepin in Insomnia, sponsored by Shenyang Funing Pharmaceutical. Started Mar 2023; status: completed.
02
Drugs
doxepin
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20230027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230027.